labetalol has been researched along with Brain Dead in 5 studies
Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Labetalol-treated pigs exhibited a significant decrease of Bmax and an increase of Kd as compared with brain-dead pigs." | 5.31 | Consequences of labetalol administration on myocardial beta adrenergic receptors in the brain dead pig. ( Aubert, N; Burlet, C; Devaux, Y; Mertes, PM; Seguin, C; Siaghy, EM; Ungureanu-Longrois, D; Zannad, F, 2000) |
| "Labetalol-treated pigs exhibited a significant decrease of Bmax and an increase of Kd as compared with brain-dead pigs." | 1.31 | Consequences of labetalol administration on myocardial beta adrenergic receptors in the brain dead pig. ( Aubert, N; Burlet, C; Devaux, Y; Mertes, PM; Seguin, C; Siaghy, EM; Ungureanu-Longrois, D; Zannad, F, 2000) |
| "Myocardial ischemia has been suggested as a possible cause." | 1.31 | Evidence of functional myocardial ischemia associated with myocardial dysfunction in brain-dead pigs. ( de Talancé, N; Devaux, Y; Grosjean, S; Mairose, P; Mertes, PM; Seguin, C; Siaghy, EM; Ungureanu-Longrois, D; Zannad, F, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mertes, PM | 4 |
| el-Abbassi, K | 1 |
| Siaghy, EM | 4 |
| Delophont, P | 1 |
| Michel, C | 1 |
| Longrois-Undergureanu, D | 1 |
| Carteaux, JP | 1 |
| Villemot, JP | 2 |
| Halejcio-Delophont, P | 1 |
| Devaux, Y | 3 |
| Richoux, JP | 1 |
| Burlet, C | 2 |
| Ungureanu-Longrois, D | 3 |
| Farhat, F | 1 |
| Loisance, D | 1 |
| Garnier, JP | 1 |
| Kirsch, M | 1 |
| Seguin, C | 2 |
| Aubert, N | 1 |
| Zannad, F | 2 |
| Grosjean, S | 1 |
| Mairose, P | 1 |
| de Talancé, N | 1 |
5 other studies available for labetalol and Brain Dead
| Article | Year |
|---|---|
[Protective effect of labetalol on cardiovascular consequences of brain death in the swine].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Brain Death; Disease Models, Ani | 1997 |
Protective effects of labetalol on myocardial contractile function in brain-dead pigs.
Topics: Animals; Blood Pressure; Brain Death; Cardiac Output; Coronary Circulation; Heart Rate; Hemodynamics | 1998 |
Norepinephrine release after acute brain death abolishes the cardioprotective effects of ischemic preconditioning in rabbit.
Topics: Animals; Brain Death; Coronary Disease; Disease Models, Animal; Female; Hemodynamics; Ischemic Preco | 2001 |
Consequences of labetalol administration on myocardial beta adrenergic receptors in the brain dead pig.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Brain Death; Heart; Hemodynamics | 2000 |
Evidence of functional myocardial ischemia associated with myocardial dysfunction in brain-dead pigs.
Topics: Adenosine; Animals; Blood Flow Velocity; Blood Gas Analysis; Blood Pressure; Brain Death; Cardiac Ou | 2001 |